REFERENCE
Eggington S, Tappenden P, Pandor A, Paisley S, Saunders M, Seymour M, Sutcliffe P, Chilcott J.Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British Journal of Cancer 95: 1195-1201, No. 9, 6 Nov 2006
Rights and permissions
About this article
Cite this article
Capecitabine, oxaliplatin acceptable adjuvant option to UK NHS. Pharmacoecon. Outcomes News 521, 6 (2007). https://doi.org/10.2165/00151234-200705210-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00017